Mr Molloy founded PPK Group Limited, then known as Plaspak Group Limited, in 1979 and has acted as a director of PPK Group Limited since that time. He has extensive experience on public company boards, and in advising publicly listed and private entities on commercial aspects of mergers, acquisitions and divestment activities.

Dr Pullen comes with over 30 years of business and strategic development experience in the medical devices, pharmaceutical and biotechnology sectors.

Greg has worked for major Australian companies such as CSL, where he was a member of the commercial team that licensed the GardasilTM HPV vaccine to Merck. He has created companies with significant equity value, and has licensed many technologies to major companies.

He is currently the Chair of private biotechnology company Virex Pharma Limited, a Non-Executive Director of White Graphene Limited, and consults on intellectual property and commercialisation issues with major Australian universities and other organisations.